First Read Russell Suite Competition Ambiguity Raises Some Questions; Exclusive. Non-exclusive. Exclusive. CME. ICE. CME again. By John Lothian The story of the Russell Index futures complex licensing over the years is a study in ambiguity, changing strategies and partners. We know the CME Group will win this round as they currently hold the long term license for the products. But what will happen in the short term is ambiguous as these two global exchange giants square off and try to maintain control or pry loose the open interest in the Russell futures products. After ICE took over an exclusive…